{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T14:23:44Z","timestamp":1789395824607,"version":"build-2803163510"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T00:00:00Z","timestamp":1518566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,2,14]],"date-time":"2018-02-14T00:00:00Z","timestamp":1518566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The global spread of Zika virus (ZIKV) and its unexpected association with congenital defects necessitates the rapid development of a safe and effective vaccine. Here we report the development and characterization of a recombinant chimeric ZIKV vaccine candidate (termed ChinZIKV) that expresses the prM-E proteins of ZIKV using the licensed Japanese encephalitis live-attenuated vaccine SA14-14-2 as the genetic backbone. ChinZIKV retains its replication activity and genetic stability in vitro, while exhibiting an attenuation phenotype in multiple animal models. Remarkably, immunization of mice and rhesus macaques with a single dose of ChinZIKV elicits robust and long-lasting immune responses, and confers complete protection against ZIKV challenge. Significantly, female mice immunized with ChinZIKV are protected against placental and fetal damage upon ZIKV challenge during pregnancy. Overall, our study provides an alternative vaccine platform in response to the ZIKV emergency, and the safety, immunogenicity, and protection profiles of ChinZIKV warrant further clinical development.<\/jats:p>","DOI":"10.1038\/s41467-018-02975-w","type":"journal-article","created":{"date-parts":[[2018,2,8]],"date-time":"2018-02-08T14:38:22Z","timestamp":1518100702000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":94,"title":["Development of a chimeric Zika vaccine using a licensed live-attenuated flavivirus vaccine as backbone"],"prefix":"10.1038","volume":"9","author":[{"given":"Xiao-Feng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Long","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Jiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Yao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-Feng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunfeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Qiang","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gong","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Chun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6628-2747","authenticated-orcid":false,"given":"Ya-Jun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Yong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0632-2807","authenticated-orcid":false,"given":"Cheng-Feng","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,14]]},"reference":[{"key":"2975_CR1","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","volume":"387","author":"VM Cao-Lormeau","year":"2016","unstructured":"Cao-Lormeau, V.-M. et al. Guillain-Barr\u00e9 syndrome outbreak associated with zika virus infection in french polynesia: a case-control study.  Lancet 387, 1531\u20131539 (2016).","journal-title":"Lancet"},{"key":"2975_CR2","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1056\/NEJMoa1601824","volume":"374","author":"RW Driggers","year":"2016","unstructured":"Driggers, R. W. et al. Zika virus infection with prolonged maternal viremia and fetal brain abnormalities. N. Engl. J. Med. 374, 2142\u20132151 (2016).","journal-title":"N. Engl. J. Med."},{"key":"2975_CR3","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1056\/NEJMoa1600651","volume":"374","author":"J Mlakar","year":"2016","unstructured":"Mlakar, J. et al. Zika virus associated with microcephaly. N. Engl. J. Med. 374, 951\u2013958 (2016).","journal-title":"N. Engl. J. Med."},{"key":"2975_CR4","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1056\/NEJMc1604449","volume":"374","author":"E D\u2019Ortenzio","year":"2016","unstructured":"D\u2019Ortenzio, E. et al. Evidence of sexual transmission of zika virus. N. Engl. J. Med. 374, 2195\u20132198 (2016).","journal-title":"N. Engl. J. Med."},{"key":"2975_CR5","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.cell.2017.02.017","volume":"168","author":"JM Richner","year":"2017","unstructured":"Richner, J. M. et al. Modified mRNA vaccines protect against zika virus infection. Cell 168, 1114\u20131125.e1110 (2017).","journal-title":"Cell"},{"key":"2975_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15743","volume":"8","author":"BD Griffin","year":"2017","unstructured":"Griffin, B. D. et al. DNA vaccination protects mice against zika virus-induced damage to the testes. Nat. Commun. 8, 15743 (2017).","journal-title":"Nat. Commun."},{"key":"2975_CR7","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/nature18952","volume":"536","author":"RA Larocca","year":"2016","unstructured":"Larocca, R. A. et al. Vaccine protection against zika virus from brazil. Nature 536, 474\u2013478 (2016).","journal-title":"Nature"},{"key":"2975_CR8","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1126\/science.aah6157","volume":"353","author":"P Abbink","year":"2016","unstructured":"Abbink, P. et al. Protective efficacy of multiple vaccine platforms against zika virus challenge in rhesus monkeys. Science 353, 1129\u20131132 (2016).","journal-title":"Science"},{"key":"2975_CR9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1126\/science.aai9137","volume":"354","author":"KA Dowd","year":"2016","unstructured":"Dowd, K. A. et al. Rapid development of a DNA vaccine for zika virus. Science 354, 237\u2013240 (2016).","journal-title":"Science"},{"key":"2975_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00737-8","volume":"8","author":"C Shan","year":"2017","unstructured":"Shan, C. et al. A single-dose live-attenuated vaccine prevents zika virus pregnancy transmission and testis damage. Nat. Commun. 8, 676 (2017).","journal-title":"Nat. Commun."},{"key":"2975_CR11","doi-asserted-by":"publisher","unstructured":"Gaudinski, M. R. et al. Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials. Lancet https:\/\/doi.org\/10.1016\/S0140-6736(17)33105-7 (2017).","DOI":"10.1016\/S0140-6736(17)33105-7"},{"key":"2975_CR12","doi-asserted-by":"publisher","unstructured":"Tebas, P. et al. Safety and immunogenicity of an anti-Zika virus DNA vaccine - preliminary report. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMoa1708120 (2017).","DOI":"10.1056\/NEJMoa1708120"},{"key":"2975_CR13","doi-asserted-by":"publisher","first-page":"5205","DOI":"10.1016\/j.vaccine.2005.07.002","volume":"23","author":"J Hombach","year":"2005","unstructured":"Hombach, J., Solomon, T., Kurane, I., Jacobson, J. & Wood, D. Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2\u20133 September, 2004. Vaccine 23, 5205\u20135211 (2005).","journal-title":"Vaccine"},{"key":"2975_CR14","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1046\/j.1365-2249.1997.4311446.x","volume":"110","author":"TR Kreil","year":"1997","unstructured":"Kreil, T. R., Burger, I., Bachmann, M., Fraiss, S. & Eibl, M. M. Antibodies protect mice against challenge with tick-borne encephalitis virus (TBEV)-infected macrophages. Clin. Exp. Immunol. 110, 358\u2013361 (1997).","journal-title":"Clin. Exp. Immunol."},{"key":"2975_CR15","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/am.25.4.539-544.1973","volume":"25","author":"RA Mason","year":"1973","unstructured":"Mason, R. A., Tauraso, N. M., Spertzel, R. O. & Ginn, R. K. Yellow fever vaccine: direct challenge of monkeys given graded doses of 17D vaccine. Appl. Microbiol. 25, 539\u2013544 (1973).","journal-title":"Appl. Microbiol."},{"key":"2975_CR16","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1084\/jem.20151517","volume":"213","author":"L Turtle","year":"2016","unstructured":"Turtle, L. et al. Human T cell responses to Japanese encephalitis virus in health and disease. J. Exp. Med. 213, 1331\u20131352 (2016).","journal-title":"J. Exp. Med."},{"key":"2975_CR17","doi-asserted-by":"publisher","first-page":"e1005786","DOI":"10.1371\/journal.ppat.1005786","volume":"12","author":"AM Watson","year":"2016","unstructured":"Watson, A. M., Lam, L. K., Klimstra, W. B. & Ryman, K. D. The 17D-204 vaccine strain-induced protection against virulent yellow fever virus is mediated by humoral immunity and CD4+but not CD8+T cells. PLoS Pathog. 12, e1005786 (2016).","journal-title":"PLoS Pathog."},{"key":"2975_CR18","doi-asserted-by":"publisher","first-page":"5405","DOI":"10.4049\/jimmunol.1001709","volume":"185","author":"LE Yauch","year":"2010","unstructured":"Yauch, L. E. et al. CD4+T cells are not required for the induction of dengue virus-specific CD8+T cell or antibody responses but contribute to protection after vaccination. J. Immunol. 185, 5405\u20135416 (2010).","journal-title":"J. Immunol."},{"key":"2975_CR19","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.06.040","volume":"170","author":"JM Richner","year":"2017","unstructured":"Richner, J. M. et al. Vaccine mediated protection against zika virus-induced congenital disease. Cell 170, 273\u2013283 e212 (2017).","journal-title":"Cell"},{"key":"2975_CR20","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nm.4322","volume":"23","author":"C Shan","year":"2017","unstructured":"Shan, C. et al. A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models. Nat. Med. 23, 763\u2013767 (2017).","journal-title":"Nat. Med."},{"key":"2975_CR21","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.vaccine.2014.10.004","volume":"33","author":"TP Monath","year":"2015","unstructured":"Monath, T. P. et al. Live virus vaccines based on a yellow fever vaccine backbone: standardized template with key considerations for a risk\/benefit assessment. Vaccine 33, 62\u201372 (2015).","journal-title":"Vaccine"},{"key":"2975_CR22","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1586\/14760584.2016.1123097","volume":"15","author":"K Chokephaibulkit","year":"2016","unstructured":"Chokephaibulkit, K., Houillon, G., Feroldi, E. & Bouckenooghe, A. Safety and immunogenicity of a live attenuated Japanese encephalitis chimeric virus vaccine (IMOJEV(R)) in children. Expert. Rev. Vaccin. 15, 153\u2013166 (2016).","journal-title":"Expert. Rev. Vaccin."},{"key":"2975_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrmicro.2015.2","volume":"14","author":"B Guy","year":"2016","unstructured":"Guy, B. & Jackson, N. Dengue vaccine: hypotheses to understand CYD-TDV-induced protection. Nat. Rev. Microbiol. 14, 45\u201354 (2016).","journal-title":"Nat. Rev. Microbiol."},{"key":"2975_CR24","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1586\/14760584.2016.1128328","volume":"15","author":"JE Osorio","year":"2016","unstructured":"Osorio, J. E., Wallace, D. & Stinchcomb, D. T. A recombinant, chimeric tetravalent dengue vaccine candidate based on a dengue virus serotype 2 backbone. Expert. Rev. Vaccin. 15, 497\u2013508 (2016).","journal-title":"Expert. Rev. Vaccin."},{"key":"2975_CR25","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1586\/14760584.2016.1115727","volume":"15","author":"SS Whitehead","year":"2016","unstructured":"Whitehead, S. S. Development of TV003\/TV005, a single dose, highly immunogenic live attenuated dengue vaccine; what makes this vaccine different from the Sanofi-Pasteur CYD vaccine? Expert Rev. Vaccines 15, 509\u2013517 (2016).","journal-title":"Expert Rev. Vaccines"},{"key":"2975_CR26","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1016\/j.vaccine.2010.02.105","volume":"28","author":"Y Yu","year":"2010","unstructured":"Yu, Y. Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities. Vaccine 28, 3635\u20133641 (2010).","journal-title":"Vaccine"},{"key":"2975_CR27","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/S0140-6736(01)05967-0","volume":"358","author":"MB Bista","year":"2001","unstructured":"Bista, M. B. et al. Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study. Lancet 358, 791\u2013795 (2001).","journal-title":"Lancet"},{"key":"2975_CR28","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/S0140-6736(96)91075-2","volume":"347","author":"S Hennessy","year":"1996","unstructured":"Hennessy, S. et al. Effectiveness of live-attenuated Japanese encephalitis vaccine (SA14-14-2): a case-control study. Lancet 347, 1583\u20131586 (1996).","journal-title":"Lancet"},{"key":"2975_CR29","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1056\/NEJMc0808664","volume":"360","author":"R Kumar","year":"2009","unstructured":"Kumar, R., Tripathi, P. & Rizvi, A. Effectiveness of one dose of SA 14-14-2 vaccine against Japanese encephalitis. N. Engl. J. Med. 360, 1465\u20131466 (2009).","journal-title":"N. Engl. J. Med."},{"key":"2975_CR30","doi-asserted-by":"publisher","first-page":"13694","DOI":"10.1128\/JVI.00931-13","volume":"87","author":"XF Li","year":"2013","unstructured":"Li, X. F. et al. A chimeric dengue virus vaccine using japanese encephalitis virus vaccine strain SA14-14-2 as backbone is immunogenic and protective against either parental virus in mice and nonhuman primates. J. Virol. 87, 13694\u201313705 (2013).","journal-title":"J. Virol."},{"key":"2975_CR31","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.chom.2016.05.004","volume":"19","author":"C Shan","year":"2016","unstructured":"Shan, C. et al. An infectious cDNA clone of zika virus to study viral virulence, mosquito transmission, and antiviral inhibitors. Cell Host Microbe 19, 891\u2013900 (2016).","journal-title":"Cell Host Microbe"},{"key":"2975_CR32","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.chom.2016.03.010","volume":"19","author":"HM Lazear","year":"2016","unstructured":"Lazear, H. M. et al. A mouse model of zika virus pathogenesis. Cell Host Microbe 19, 720\u2013730 (2016).","journal-title":"Cell Host Microbe"},{"key":"2975_CR33","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1080\/21645515.2016.1219004","volume":"12","author":"NN Zhang","year":"2016","unstructured":"Zhang, N. N. et al. Characterization of the contemporary Zika virus in immunocompetent mice. Hum. Vaccin. Immunother. 12, 3107\u20133109 (2016).","journal-title":"Hum. Vaccin. Immunother."},{"key":"2975_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12204","volume":"7","author":"DM Dudley","year":"2016","unstructured":"Dudley, D. M. et al. A rhesus macaque model of Asian-lineage Zika virus infection. Nat. Commun. 7, 12204 (2016).","journal-title":"Nat. Commun."},{"key":"2975_CR35","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ebiom.2016.09.022","volume":"12","author":"XF Li","year":"2016","unstructured":"Li, X. F. et al. Characterization of a 2016 clinical isolate of zika virus in non-human primates. EbioMedicine 12, 170\u2013177 (2016).","journal-title":"EbioMedicine"},{"key":"2975_CR36","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1038\/nm.4206","volume":"22","author":"CE Osuna","year":"2016","unstructured":"Osuna, C. E. et al. Zika viral dynamics and shedding in rhesus and cynomolgus macaques. Nat. Med. 22, 1448\u20131455 (2016).","journal-title":"Nat. Med."},{"key":"2975_CR37","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1586\/14760584.2015.1083430","volume":"14","author":"AS Beck","year":"2015","unstructured":"Beck, A. S. & Barrett, A. D. Current status and future prospects of yellow fever vaccines. Expert. Rev. Vaccin. 14, 1479\u20131492 (2015).","journal-title":"Expert. Rev. Vaccin."},{"key":"2975_CR38","doi-asserted-by":"publisher","first-page":"4761","DOI":"10.1128\/JVI.78.9.4761-4775.2004","volume":"78","author":"F Guirakhoo","year":"2004","unstructured":"Guirakhoo, F. et al. Safety and efficacy of chimeric yellow Fever-dengue virus tetravalent vaccine formulations in nonhuman primates. J. Virol. 78, 4761\u20134775 (2004).","journal-title":"J. Virol."},{"key":"2975_CR39","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/j.celrep.2016.07.049","volume":"16","author":"KA Dowd","year":"2016","unstructured":"Dowd, K. A. et al. Broadly neutralizing activity of zika virus-immune sera identifies a single viral serotype. Cell Rep. 16, 1485\u20131491 (2016).","journal-title":"Cell Rep."},{"key":"2975_CR40","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.chom.2016.12.010","volume":"21","author":"A Elong Ngono","year":"2017","unstructured":"Elong Ngono, A. et al. Mapping and role of the CD8+T cell response during primary zika virus infection in mice. Cell Host Microbe 21, 35\u201346 (2017).","journal-title":"Cell Host Microbe"},{"key":"2975_CR41","doi-asserted-by":"publisher","first-page":"e1006004","DOI":"10.1371\/journal.ppat.1006004","volume":"12","author":"M Manangeeswaran","year":"2016","unstructured":"Manangeeswaran, M., Ireland, D. D. & Verthelyi, D. Zika (PRVABC59) infection is associated with T cell infiltration and neurodegeneration in CNS of immunocompetent neonatal C57Bl\/6 Mice. PLoS Pathog. 12, e1006004 (2016).","journal-title":"PLoS Pathog."},{"key":"2975_CR42","doi-asserted-by":"publisher","first-page":"5712","DOI":"10.1016\/j.vaccine.2008.08.019","volume":"26","author":"B Guy","year":"2008","unstructured":"Guy, B. et al. Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects. Vaccine 26, 5712\u20135721 (2008).","journal-title":"Vaccine"},{"key":"2975_CR43","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S1473-3099(16)30070-6","volume":"16","author":"FC Zhang","year":"2016","unstructured":"Zhang, F. C., Li, X. F., Deng, Y. Q., Tong, Y. G. & Qin, C. F. Excretion of infectious Zika virus in urine. Lancet Infect. Dis. 16, 641\u2013642 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"2975_CR44","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1126\/science.aal4365","volume":"356","author":"SV Bardina","year":"2017","unstructured":"Bardina, S. V. et al. Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity. Science 356, 175\u2013180 (2017).","journal-title":"Science"},{"key":"2975_CR45","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.stem.2016.04.017","volume":"19","author":"C Li","year":"2016","unstructured":"Li, C. et al. Zika virus disrupts neural progenitor development and leads to microcephaly in mice. Cell Stem Cell 19, 120\u2013126 (2016).","journal-title":"Cell Stem Cell"},{"key":"2975_CR46","doi-asserted-by":"publisher","first-page":"3895","DOI":"10.1016\/j.vaccine.2011.03.038","volume":"29","author":"VJ Gunther","year":"2011","unstructured":"Gunther, V. J. et al. A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness. Vaccine 29, 3895\u20133904 (2011).","journal-title":"Vaccine"},{"key":"2975_CR47","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1099\/vir.0.059436-0","volume":"94","author":"XF Li","year":"2013","unstructured":"Li, X. F. et al. Development of chimaeric West Nile virus attenuated vaccine candidate based on the Japanese encephalitis vaccine strain SA14-14-2. J. Gen. Virol. 94, 2700-2709 (2013).","journal-title":"J. Gen. Virol."},{"key":"2975_CR48","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1126\/science.aam7120","volume":"358","author":"L Yuan","year":"2017","unstructured":"Yuan, L. et al. A single mutation in the prM protein of Zika virus contributes to fetal microcephaly. Science 358, 933\u2013936 (2017).","journal-title":"Science"},{"key":"2975_CR49","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.vaccine.2013.12.050","volume":"32","author":"HJ Wang","year":"2014","unstructured":"Wang, H. J. et al. Recombinant chimeric Japanese encephalitis virus\/tick-borne encephalitis virus is attenuated and protective in mice. Vaccine 32, 949\u2013956 (2014).","journal-title":"Vaccine"},{"key":"2975_CR50","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/0264-410X(88)90103-X","volume":"6","author":"KH Eckels","year":"1988","unstructured":"Eckels, K. H. et al. Japanese encephalitis virus live-attenuated vaccine, Chinese strain SA14-14-2; adaptation to primary canine kidney cell cultures and preparation of a vaccine for human use. Vaccine 6, 513\u2013518 (1988).","journal-title":"Vaccine"},{"key":"2975_CR51","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1093\/infdis\/171.5.1144","volume":"171","author":"H Sumiyoshi","year":"1995","unstructured":"Sumiyoshi, H., Tignor, G. H. & Shope, R. E. Characterization of a highly attenuated Japanese encephalitis virus generated from molecularly cloned cDNA. J. Infect. Dis. 171, 1144\u20131151 (1995).","journal-title":"J. Infect. Dis."},{"key":"2975_CR52","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nature21428","volume":"543","author":"N Pardi","year":"2017","unstructured":"Pardi, N. et al. Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination. Nature 543, 248\u2013251 (2017).","journal-title":"Nature"},{"key":"2975_CR53","doi-asserted-by":"publisher","first-page":"17036","DOI":"10.1038\/nmicrobiol.2017.36","volume":"2","author":"J Wen","year":"2017","unstructured":"Wen, J. et al. Identification of Zika virus epitopes reveals immunodominant and protective roles for dengue virus cross-reactive CD8+T cells. Nat. Microbiol. 2, 17036 (2017).","journal-title":"Nat. Microbiol."},{"key":"2975_CR54","doi-asserted-by":"publisher","first-page":"e1006219","DOI":"10.1371\/journal.ppat.1006219","volume":"13","author":"AJ Hirsch","year":"2017","unstructured":"Hirsch, A. J. et al. Zika Virus infection of rhesus macaques leads to viral persistence in multiple tissues. PLoS Pathog. 13, e1006219 (2017).","journal-title":"PLoS Pathog."},{"key":"2975_CR55","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/nprot.2017.066","volume":"12","author":"J Quick","year":"2017","unstructured":"Quick, J. et al. Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples. Nat. Protoc. 12, 1261\u20131276 (2017).","journal-title":"Nat. Protoc."},{"key":"2975_CR56","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/ana.24839","volume":"81","author":"AM Ornelas","year":"2017","unstructured":"Ornelas, A. M. et al. Immune activation in amniotic fluid from Zika virus-associated microcephaly. Ann. Neurol. 81, 152\u2013156 (2017).","journal-title":"Ann. Neurol."},{"key":"2975_CR57","doi-asserted-by":"publisher","first-page":"e0004828","DOI":"10.1371\/journal.pntd.0004828","volume":"10","author":"HR Chen","year":"2016","unstructured":"Chen, H. R. et al. Dengue virus nonstructural protein 1 induces vascular leakage through macrophage migration inhibitory factor andautophagy. PLoS Negl. Trop. Dis. 10, e0004828 (2016).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"2975_CR58","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.cyto.2011.01.013","volume":"54","author":"YC Chuang","year":"2011","unstructured":"Chuang, Y. C. et al. Macrophage migration inhibitory factor induced by dengue virus infection increases vascular permeability. Cytokine 54, 222\u2013231 (2011).","journal-title":"Cytokine"},{"key":"2975_CR59","doi-asserted-by":"publisher","first-page":"e0004830","DOI":"10.1371\/journal.pntd.0004830","volume":"10","author":"A Harenberg","year":"2016","unstructured":"Harenberg, A. et al. Cytokine profile of children hospitalized with virologically-confirmed dengue during two Phase III Vaccine Efficacy Trials. PLoS Negl. Trop. Dis. 10, e0004830 (2016).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"2975_CR60","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1084\/jem.20042530","volume":"202","author":"WG Glass","year":"2005","unstructured":"Glass, W. G. et al. Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J. Exp. Med. 202, 1087\u20131098 (2005).","journal-title":"J. Exp. Med."},{"key":"2975_CR61","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1084\/jem.20051970","volume":"203","author":"WG Glass","year":"2006","unstructured":"Glass, W. G. et al. CCR5 deficiency increases risk of symptomatic West Nile virus infection. J. Exp. Med. 203, 35\u201340 (2006).","journal-title":"J. Exp. Med."},{"key":"2975_CR62","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nature18938","volume":"536","author":"G Barba-Spaeth","year":"2016","unstructured":"Barba-Spaeth, G. et al. Structural basis of potent Zika-dengue virus antibody cross-neutralization. Nature 536, 48\u201353 (2016).","journal-title":"Nature"},{"key":"2975_CR63","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nature18296","volume":"534","author":"FR Cugola","year":"2016","unstructured":"Cugola, F. R. et al. The Brazilian zika virus strain causes birth defects in experimental models. Nature 534, 267\u2013271 (2016).","journal-title":"Nature"},{"key":"2975_CR64","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/1743-422X-10-64","volume":"10","author":"SH Li","year":"2013","unstructured":"Li, S. H. et al. Development and characterization of the replicon system of japanese encephalitis live vaccine virus SA14-14-2. Virol. J. 10, 64 (2013).","journal-title":"Virol. J."},{"key":"2975_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-10595-5","volume":"7","author":"JF Han","year":"2017","unstructured":"Han, J. F. et al. Immunization with truncated envelope protein of Zika virus induces protective immune response in mice. Sci. Rep. 7, 10047 (2017).","journal-title":"Sci. Rep."},{"key":"2975_CR66","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1021\/es60130a004","volume":"11","author":"MA Hamilton","year":"1977","unstructured":"Hamilton, M. A., C., R. R. & V., T. R. Trimmed Spearman-Karber method for estimating median lethal concentration in toxicity bioassays. Environ. Sci. Technol. 11, 714\u2013719 (1977).","journal-title":"Environ. Sci. Technol."},{"key":"2975_CR67","first-page":"493","volume":"27","author":"LJ Reed","year":"1938","unstructured":"Reed, L. J. & Muench, H. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27, 493\u2013497 (1938).","journal-title":"Am. J. Hyg."},{"key":"2975_CR68","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/nature22365","volume":"545","author":"Y Liu","year":"2017","unstructured":"Liu, Y. et al. Evolutionary enhancement of zika virus infectivity in Aedes aegypti mosquitoes. Nature 545, 482\u2013486 (2017).","journal-title":"Nature"},{"key":"2975_CR69","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.stem.2016.04.014","volume":"19","author":"J Dang","year":"2016","unstructured":"Dang, J. et al. Zika virus depletes neural progenitors in human cerebral organoids through activation of the innate immune receptor TLR3. Cell Stem Cell 19, 258\u2013265 (2016).","journal-title":"Cell Stem Cell"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-02975-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-02975-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-02975-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T13:06:36Z","timestamp":1671541596000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-02975-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,14]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["2975"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-02975-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,14]]},"assertion":[{"value":"28 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"C.F.Q. has filed a patent about the technology and the relevant vaccine products described in the paper. The remaining\u00a0authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"673"}}